SUVENPHAR.BOSUVENPHAR.BOBSE
Loading
| Metric | Mar 21 | Mar 22 | Mar 23 |
|---|---|---|---|
| Revenue | 10,097 | 13,202 | 13,403 |
| Gross Profit | 5,725 | 7,461 | 7,521 |
| Operating Income | 4,831 | 6,334 | 6,304 |
| Net Income | 3,623 | 4,538 | 4,113 |
| EBITDA | 4,407 | 5,795 | 5,726 |
| EPS Diluted | 14.23 | 17.83 | 16.16 |
| Metric | Mar 21 | Mar 22 | Mar 23 |
|---|---|---|---|
| Cash & Equivalents | 72 | 446 | 648 |
| Total Current Assets | 5,648 | 11,279 | 10,110 |
| Total Assets | 14,745 | 18,296 | 19,657 |
| Total Current Liabilities | 2,197 | 2,103 | 1,588 |
| Total Liabilities | 2,937 | 3,024 | 2,306 |
| Total Equity | 11,808 | 15,272 | 17,352 |
| Total Debt | 1,430 | 971 | 703 |
| Net Debt | 1,359 | 526 | 55 |
| Metric | Mar 21 | Mar 22 | Mar 23 |
|---|---|---|---|
| Operating Cash Flow | 3,834 | 3,300 | 4,509 |
| Capital Expenditure | -1,108 | -752 | -2,858 |
| Free Cash Flow | 2,726 | 2,548 | 1,651 |
| Stock-Based Comp | 0 | 0 | 0 |
| Net Change in Cash | -45 | 374 | 202 |